List view / Grid view
An assay is an analytical procedure in laboratory medicine, pharmacology and molecular biology for measuring the activity of a target entity.
20 May 2015 | By PerkinElmer
EnVision® Multilabel Plate Reader provides high speed, ultra high-throughput and maximum sensitivity across all detection technologies, so that your high throughput screening applications...
23 April 2015 | By Thermo Fisher Scientific
The Thermo Scientific Multidrop Combi is a reagent dispenser offering unrivalled levels of flexibility and performance to meet the requirements of reagent dispensing in pharmaceutical and biotechnology laboratories...
23 April 2015 | By Thermo Fisher Scientific
The Thermo Scientific Varioskan LUX Multimode Microplate Reader is designed for bioscience researchers with a wide variety of needs...
23 April 2015 | By Abcam
MMP Activity Assay Kit (Fluorometric - Red, ab112147) uses a fluorescence resonance energy transfer (FRET) peptide as a MMP substrate...
Sheraz Gul, Head of Biology at Fraunhofer-IME SP, provides an in-depth review of the Cell-Based Assays for Screening workshop which took place in December 2014...
1 April 2015 | By Avacta Life Sciences
Lys-6-linked chains may be involved in DNA repair. Affimers are engineered to outperform antibodies and aptamers...
1 April 2015 | By Avacta Life Sciences
Lys-33-linked chains are believed to be involved in kinase modification. Affimers are engineered to outperform antibodies and aptamers...
1 April 2015 | By Avacta Life Sciences
Lys-48-linked chains are involved in protein degradation via the proteasome. Affimers are engineered to outperform antibodies and aptamers...
1 April 2015 | By Avacta Life Sciences
A ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer...
30 March 2015 | By Victoria White
CRT and BioInvent have announced the start of a two-year research collaboration with leading antibody researchers at the University of Southampton...
6 February 2015 | By
Head of Drug Discovery at the Fraunhofer Institute for Molecular Biology and Applied Ecology
Heat shock proteins (HSPs) have been proposed as therapeutic targets for novel anticancer agents. However, candidates have thus far failed due to low tolerability, limiting their efficacy. This failure highlights our current inability to predict drug toxicity in patients, a Holy Grail in modern drug discovery. Paradoxically, the fundamental role…
